title: Pharmacokinetics of reboxetine enantiomers in the dog.
abstract: Reboxetine, (RS)-2-[(RS)-alpha-(2-ethoxyphenoxy)benzyl]morpholine methanesulphonate, is a racemic compound and consists of a mixture of the (R,R)- and (S,S)-enantiomers. The pharmacokinetics of reboxetine enantiomers were determined in a crossover study in three male beagle dogs. Each animal received the following oral treatments, separated by 1-week washout period: 10 mg/kg reboxetine, 5 mg/kg (R,R)- and 5 mg/kg (S,S)-. Plasma and urinary levels of the reboxetine enantiomers were monitored up to 48 h post-dosing using an enantiospecific HPLC method with fluorimetric detection (LOQ: 1.1 ng/ml in plasma and 5 ng/ml in urine for each enantiomer). After reboxetine administration mean tmax was about 1 h for both enantiomers. Cmax and AUC were about 1.5 times higher for the (R,R)- than for the (S,S)-enantiomer, mean values +/- SD being 704 +/- 330 and 427 +/- 175 ng/ml for Cmax and 2,876 +/- 1,354 and 1,998 +/- 848 ng.h/ml for AUC, respectively. No differences between the (R,R)- and (S,S)-enantiomers were observed in t1/2 (3.9 h). Total recovery of the two enantiomers in urine was similar, the Ae (0-48 h) being 1.3 +/- 0.7 and 1.1 +/- 0.7% of the enantiomer dose for the (R,R)- and the (S,S)-enantiomers, respectively. No marked differences in the main plasma pharmacokinetic parameters were found for either enantiomer on administration of the single enantiomers or reboxetine. No chiral inversion was observed after administration of the separate enantiomers, as already observed in humans.
authors.affiliation: Pharmacokinetics and Metabolism Department, Pharmacia & Upjohn, Milan, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Frigerio
authors.forename: A
authors.initials: A
authors.lastname: Benecchi
authors.forename: G
authors.initials: G
authors.lastname: Brianceschi
authors.forename: C
authors.initials: C
authors.lastname: Pellizzoni
authors.forename: I
authors.initials: I
authors.lastname: Poggesi
authors.forename: M
authors.initials: M
authors.lastname: Strolin Benedetti
authors.forename: P
authors.initials: P
authors.lastname: Dostert
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D019540:Area Under Curve; D002851:Chromatography, High Pressure Liquid; D004285:Dogs; D006207:Half-Life; D008297:Male; D009025:Morpholines / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D000077593:Reboxetine; D013050:Spectrometry, Fluorescence; D013237:Stereoisomerism
chemical_list: D000928:Antidepressive Agents; D009025:Morpholines; D000077593:Reboxetine